.svg){kind=small}
Oct-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Is this your brand?
See your full sales and distribution data: where you sell, how you're priced, and how you rank against the brands next to you on the shelf.
See your brand's dataCarry this brand in your store?
Headset Retailer is free. Connect your POS and see what's selling and what's sitting.
Sign up freeWhere to Buy
Entourage Cannabis / CBDiscovery is stocked at 382 licensed dispensaries across Oregon, Florida, and Oklahoma, 318 of them in Oregon, with the deepest coverage in Portland, Eugene, Salem, Bend, and Medford. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Entourage Cannabis / CBDiscovery concentrated 83.83% of October 2026 sales in Vapor Pens, where sales were down 12.38% year over year but up 2.68% month over month, while Pre-Roll held 9.60% with a 2.23% YoY increase and 1.28% MoM lift. Concentrates accounted for 6.50% after a 44.49% YoY decline despite a 6.96% MoM uptick, and the brand’s average price fell 3.82% YoY to $24.45 as Vapor Pen pricing sat at $27.77. With total brand sales down 14.37% YoY alongside a 24-month decline of 31.97%, the mix indicates dependence on a single category where short-term momentum offsets longer-run erosion, implying that category breadth is insufficient to counter sustained declines.
Holding rank 1 in Vapor Pens in Oregon while Vapor Pens carry 83.83% share suggests a defensible anchor that supports near-term MoM gains of 2.68% but also concentrates risk given the 12.38% YoY drop. The simultaneous 2.23% YoY growth in Pre-Roll and 6.96% MoM rise in Concentrates, despite a 44.49% YoY fall, points to incremental diversification levers that could mitigate the brand’s 14.37% YoY sales decline if mix shifts raise Pre-Roll above its current 9.60% share and stabilize Concentrates beyond short-cycle volatility; the implication is that maintaining the top Vapor Pen position while deliberately reweighting toward expanding sub-lines is the path to reducing exposure to category-specific downswings.
Competitive Landscape
Entourage Cannabis / CBDiscovery holds rank #1 in Oregon Vapor Pens in October 2026, unchanged YoY from rank #1, after rising from #2 three months ago, while category peers show mixed momentum: Buddies is at #2 with a -8.2% YoY sales change, and FRESHY advanced from #5 to #3 on 11.9% YoY growth; meanwhile, Mule Extracts slipped from #3 to #4 with -13.6% YoY decline, and Loot Bar climbed from #8 to #5 with 24.5% YoY growth, indicating that Entourage Cannabis / CBDiscovery’s peak at #1 in October 2026 amid both declining (#2, -8.2%) and accelerating (#5, +24.5%) competitors implies a defended leadership position likely sustained by share consolidation rather than category expansion.
Notable Products
Entourage Cannabis / CBDiscovery leans on fresh launches in October 2026, with 233 new products generating 57.8% of brand sales and several appearing in the top set, such as Alligator Blood Live Resin Disposable (1g) and Strawanna Live Resin Cartridge (1g). That tilt toward recent items indicates much of its revenue comes from newly introduced SKUs, not long-running staples.
Peer avg: average price of the same product type and package size in the same states that month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
